2m 2m 2m 2m 2m 2m 2m
JANUX THERAPEUTS (JANX)
NASDAQ
$14.65-$0.26 (-1.76%)
Price as of Jun 23, 2026 6:37 PM EDT- $874.5MMarket Cap
- -37.33%1-Year Change
- BiotechnologyIndustry
JANUX THERAPEUTS (JANX)
$14.65-$0.26 (-1.76%)
JANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.91 | ||
Change | +$0.12 (+0.84%) | ||
Open | $14.30 | ||
High | $15.01 | ||
Low | $14.30 | ||
Previous Close | $14.34 | ||
Volume | 1,188,650 | ||
30-Day Average Volume | 874,316 | ||
1-Week Change | 4.37% | ||
1-Month Change | -1.24% | ||
1-Year Change | -37.33% | ||
3-Year Change | 18.32% | ||
5-Year Change | -34.94% | ||
Fundamentals | |||
Shares Outstanding | 61.0M | ||
Total Assets | $1.0B | ||
Market Cap | $874.5M | ||
Enterprise Value | $822.7M | ||
Period: QTR TTM FY | |||
Revenue | $3.7M | ||
Net Income | -$24.4M | ||
Free Cash Flow | -$12.6M | ||
EBIT | -$24.4M | ||
EBITDA | -$23.9M | ||
Net Working Capital | $943.1M | ||
EPS | -$0.39 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 220 | ||
P/B | 1 | ||
P/E | -37 | ||
PEG | -2 | ||
Price/Free Cash Flow | -69 | ||
Price/Operating Cash Flow | -71 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue